Pot stocks

An under-recognized bullish force in equity markets. Plus, the cannabis comeback and two stock picks from one of Canada’s top value investors

The cannabis comeback: Why Aphria’s shares tripled in one month - and the whole sector is booming. Again.

Why you should own bonds when they yield almost nothing. Plus, Brookfield spinoff defies investor expectations and stock hunting for a Biden presidency

Market risks ‘arguably the highest’ in decades. Plus, the best ETFs for retirement income and what pot stocks look like two years after legalization

Canopy Growth to close two greenhouses, lay off 500 employees

Constellation appoints one of its own as Canopy Growth CEO

The verdict is in, and Year One of legalized cannabis in Canada was a dud

CannTrust allegedly used fake walls to hide pot from Health Canada

Canadian pension funds buy cannabis stocks

Constellation Brands cuts profit outlook partly on Canopy Growth deal costs

Aphria’s dealmaker: How a self-described outsider found himself in the hot seat

Quitting for cannabis: Meet seven entrepreneurs leaping into green territory

Canada’s cannabis growers behind on first recreational marijuana orders as Oct. 17 looms

Still want to ride the cannabis boom? Six bets to play the green gold rush

Bearish bets against global marijuana boom increase to record

For new marijuana ETFs, it’s been a really rough start